Related Experiment Video

Updated: Jun 27, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer

Denis Tvorogov1, Maria Sundvall, Kari Kurppa

  • 1MediCity Research Laboratory and Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland.

The Journal of Biological Chemistry
|December 23, 2008
PubMed

Insights

Somatic mutations in ErbB4 (a cancer-related receptor tyrosine kinase) can disrupt its kinase activity. These ErbB4 mutations selectively alter cancer cell signaling pathways, impacting cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) family, including ErbB2 and ErbB4, are crucial in cancer development.
  • While EGFR and ErbB2 are established cancer drug targets, ErbB4's role remains debated.
  • Somatic mutations in ErbB4 have been identified in various cancers, but their functional impact is unclear.

Purpose of the Study:

  • To investigate the functional significance of cancer-associated ErbB4 mutations.
  • To determine if ErbB4 mutations affect its kinase activity and downstream signaling pathways.

Main Methods:

  • Analysis of ErbB4 kinase activity in cancer-associated mutants.
  • Assessment of ErbB4 heterodimerization with ErbB2.
  • Evaluation of downstream signaling pathways including Erk1/2, Akt, and STAT5 phosphorylation.
  • Cellular differentiation assays using MDA-MB-468 mammary carcinoma cells.

Main Results:

  • Two out of ten cancer-associated ErbB4 mutations resulted in loss of kinase activity due to disrupted structural features.
  • Kinase-dead ErbB4 mutants effectively formed heterodimers with ErbB2 and activated Erk1/2 and Akt signaling in an ErbB2-dependent manner.
  • Mutant ErbB4 receptors failed to phosphorylate STAT5 and inhibited mammary carcinoma cell differentiation.

Conclusions:

  • Somatic ErbB4 mutations identified in cancer patients have functional consequences.
  • These mutations lead to selective alterations in ErbB4 signaling, impacting pathways crucial for cell differentiation and potentially cancer progression.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...